健康科学杂志

  • 国际标准期刊号: 1108-7366
  • 期刊 h 指数: 51
  • 期刊引用分数: 10.69
  • 期刊影响因子: 9.13
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • CINAHL 完整
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • EMCare
  • OCLC-WorldCat
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
分享此页面

抽象的

Cell Therapy Advancements for Immunological Conditions

Odam SG*, Shippman J

Cell therapy has emerged as a ground-breaking approach in the field of immunology, presenting new opportunities for the treatment of various immunological conditions. This innovative therapeutic strategy involves utilizing living cells to enhance or suppress the immune response, depending on the specific disease being targeted. In this abstract, we explore the applications of cell therapy in immunological disorders, including autoimmune diseases, cancer immunotherapy, immunodeficiencies, allergic disorders, and transplantation. Specifically, we discuss the use of regulatory T-cells (Tregs) to suppress autoimmunity, chimeric antigen receptor T-cell (CAR-T) therapy for cancer treatment, and hematopoietic stem cell transplantation (HSCT) for immunodeficiencies. Furthermore, we highlight the challenges associated with cell therapy, including safety concerns, personalized approaches, cost, and long-term efficacy. Despite these challenges, cell therapy holds great promise, paving the way for transformative advancements in immunology and offering hope for improved treatment outcomes and potential cures for patients with immunological conditions. Continued research and development in this area will undoubtedly shape the future of immunology and pave the way for personalized, effective, and accessible cell-based treatments.

Keywords

Cell therapy; Immunology; Autoimmune disorders; Cancer immunotherapy; Regulatory T-Cells; Chimeric antigen receptor T-Cells (CAR-T); Hematopoietic stem cell transplantation (HSCT); Immunodeficiency

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证